Detection of prostate-specific antigen immunoreactivity in breast tumors
โ Scribed by Eleftherios P. Diamandis; He Yu; Donald J. A. Sutherland
- Publisher
- Springer US
- Year
- 1994
- Tongue
- English
- Weight
- 896 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate-specific antigen (PSA) is a glycoprotein produced by the epithelial cells of the prostate. PSA is currently used clinically to diagnose and monitor prostate carcinoma. In previous work we have demonstrated that 30% of breast tumors and, more rarely other tumors, contain significant amounts
Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that